NCT00404768 - The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 12, 2007

Primary Completion Date

July 7, 2011

Study Completion Date

July 7, 2011

Conditions

Obstetric Labour, Premature

Interventions

DRUG

GSK221149A

6mg/h and 12 mg/h

DRUG

Placebo

Matched Placebo to Drug

Trial Locations (57)

1181

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

1259

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

1431

GSK Investigational Site, Sofia

10032

GSK Investigational Site, New York

19102

GSK Investigational Site, Philadelphia

19140

GSK Investigational Site, Philadelphia

19718

GSK Investigational Site, Newark

27103

GSK Investigational Site, Winston-Salem

27514

GSK Investigational Site, Chapel Hill

28040

GSK Investigational Site, Madrid

28388

GSK Investigational Site, Southern Pines

29201

GSK Investigational Site, Columbia

29425

GSK Investigational Site, Charleston

36604

GSK Investigational Site, Mobile

37403

GSK Investigational Site, Chattanooga

38119

GSK Investigational Site, Memphis

45267

GSK Investigational Site, Cincinnati

46009

GSK Investigational Site, Valencia

48903

GSK Investigational Site, Barakaldo (Vizcaya)

55454

GSK Investigational Site, Minneapolis

59037

GSK Investigational Site, Lille

63023

GSK Investigational Site, St Louis

66160

GSK Investigational Site, Kansas City

72401

GSK Investigational Site, Jonesboro

75679

GSK Investigational Site, Paris

77030

GSK Investigational Site, Houston

77054

GSK Investigational Site, Houston

78300

GSK Investigational Site, Poissy

83404

GSK Investigational Site, Idaho Falls

84088

GSK Investigational Site, West Jordan

84124

GSK Investigational Site, Salt Lake City

85008

GSK Investigational Site, Phoenix

85013

GSK Investigational Site, Phoenix

85712

GSK Investigational Site, Tucson

90033

GSK Investigational Site, Los Angeles

92141

GSK Investigational Site, Clamart

92150

GSK Investigational Site, Suresnes

92324

GSK Investigational Site, Colton

92350

GSK Investigational Site, Loma Linda

229899

GSK Investigational Site, Singapore

07101-1709

GSK Investigational Site, Newark

37920-1511

GSK Investigational Site, Knoxville

77555-0587

GSK Investigational Site, Galveston

23507-1914

GSK Investigational Site, Norfolk

Unknown

GSK Investigational Site, Sofia

GSK Investigational Site, Bogotá

LT-50009

GSK Investigational Site, Kaunas

LT-10207

GSK Investigational Site, Vilnius

00935

GSK Investigational Site, San Juan

120-752

GSK Investigational Site, Seoul

137-701

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

08035

GSK Investigational Site, Barcelona

CV34 5BW

GSK Investigational Site, Warwick

CV2 2DX

GSK Investigational Site, Coventry

SE1 7EH

GSK Investigational Site, London

W12 0NN

GSK Investigational Site, London